June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

RPT-UPDATE 1-Canada sure that all COVID-19 vaccines are safe, including AstraZeneca doses - PM

Published 2021-03-15, 12:29 p/m

(Repeats to fix AstraZeneca (NASDAQ:AZN) spelling in story label)

OTTAWA, March 15 (Reuters) - Canadian health experts are sure all COVID-19 vaccines being administered in the country are safe, including those made by AstraZeneca PLC AZN.L , Prime Minister Justin Trudeau told reporters on Monday.

Germany became the latest in a number of European nations that have stopped using AstraZeneca doses on Monday after reports of recipients falling ill. health experts ... collect data continuously and they assure us that all the vaccines offered in Canada are safe and effective, including those from AstraZeneca," Trudeau told a televised news conference in Montreal.

"We are obviously watching what is happening with a specific batch in Europe. We can reassure all Canadians that no AstraZeneca doses came from the same batch," he said.

Canada approved the AstraZeneca vaccine last month and has ordered 20 million doses. Ottawa has also secured an additional 2 million doses through an agreement with the Serum Institute of India and expects to get them by mid-May. spoke at an event with Francois Legault, premier of the populous province of Quebec, who said the provincial health ministry felt the AstraZeneca vaccine posed no risks.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.